Digita Selects Netmore Platform-as-a-Service to Scale LoRaWAN®-based IoT Network Capabilities in Finland
2.12.2024 08:00:00 CET | Business Wire | Press release
Digita and Netmore to Jointly Develop Large-Scale Projects in Utility, Building, Construction, and Logistics Verticals
Netmore Group, a leading global LoRaWAN network operator, today announced that Digita, a Finnish technology company specializing in broadcast networks and telecom services, has selected Netmore’s Operator Platform-as-a-Service (PaaS) to expand, optimize, and scale its LoRaWAN network capabilities for the delivery of Internet of Things (IoT) applications in Finland. The leading domestic network operator, Digita offers a complete infrastructure for IoT services including a nationwide public LoRaWAN network and private network build outs based on customer needs.
With an extensive and growing base of digital transformation deployments across the utility, district heating, smart building, and logistics verticals, Digita selected Netmore’s PaaS offering to reduce the number of systems needed to deliver IoT connectivity to its customers. In addition to streamlining its operations, Digita benefits from economies of scale derived from the shared efficiencies of Netmore’s platform which is used to manage core network and connected device services for the largest carrier-grade LoRaWAN networks in the world.
Digita supports its domestic customers with cost-effective future-proof IoT connectivity and through international roaming cooperation can now easily expand into new markets outside of Finland where Netmore and its partners operate LoRaWAN networks. Further, Netmore customers have immediate access to the Digita network to support business opportunities in Finland, providing Digita with new customer revenue streams.
“Designed for massive IoT and for provisioning and managing millions of devices, Netmore PaaS provides the advanced features and future-proof connectivity we need to scale our IoT business,” said VP, IoT Tuomas Kolkka at Digita. “Our companies have a shared vision of what is needed to support digital transformation across industries and an alignment on customer-centric business practices that will drive adoption faster.”
This collaboration significantly expands the IoT capabilities available to businesses in Finland, facilitating seamless integration of digital solutions that promote both economic growth and environmental sustainability.
“The growing demand for reliable and scalable IoT solutions in support of resource conservation and sustainability initiatives is driving the adoption of Netmore PaaS across the globe,” said Andreas Stenhager, Chief Commercial Officer at Netmore Group. “Digita’s strong market presence in Finland will enable new innovations in the delivery of digital services and we are excited to have them join our growing Operator PaaS ecosystem. Together, we are setting a new standard for IoT deployments and digital transformation, not just in Finland, but across the broader European and global markets.”
A trusted expert in network and device migrations, Netmore ensures an interruption-free migration process, keeping IoT operations running smoothly with no downtime. For more information on deploying or migrating to Netmore’s Platform-as-a-Service, contact info@netmoregroup.com.
About Netmore Group
Netmore Group is an IoT network operator, building the leading multinational network to advance sustainable business practices. We offer a reliable network platform and leading connectivity expertise for efficient measuring, monitoring, and optimisation of resource use. With 10 years in the industry, we have a solid track record, operating borderless on the European market and have grown to become a leading global network operator. Netmore group’s main owner is the Nordic infrastructure investor Polar Structure.
About Digita
Digita is a provider of digital infrastructure and services and is Finland’s largest independent owner of telecommunication masts. The company owns and operates Finland’s leading terrestrial network for nationwide TV and radio transmissions, is a pay-TV operator on the terrestrial television network and develops broadcasting services for the future. Digita’s telecommunications services include private networks, indoor coverage solutions, management services for rooftop telecommunications installations, IoT and data center services. The company provides services to media companies, consumers, mobile phone operators, industry, infrastructure enterprises and real estate owners. www.digita.fi
View source version on businesswire.com: https://www.businesswire.com/news/home/20241201696580/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
U.S. FDA Grants Priority Review to BeOne Medicines’ BRUKINSA Combination in First-Line Mantle Cell Lymphoma4.11.2026 15:13:00 CET | Press release
If approved, BRUKINSA plus rituximab would be the first and only chemotherapy-free, BTK inhibitor-based regimen for adult patients with previously untreated mantle cell lymphomaApplication supported by Phase 3 MANGROVE data, showing a 43% reduction in the risk of progression or death versus bendamustine plus rituximabFull MANGROVE results to be presented during the Plenary Scientific Session at the 68th American Society of Hematology Annual Meeting BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced that the U.S. Food and Drug Administration (FDA) has accepted and granted Priority Review to the supplemental New Drug Application (sNDA) for BRUKINSA® (zanubrutinib) in combination with rituximab for the treatment of adult patients with previously untreated mantle cell lymphoma (MCL). The application is supported by data from the pivotal Phase 3 MANGROVE study, in which this chemotherapy-free regimen significantly reduced the risk of dis
Rimini Street Awarded CANUT Third-Party Maintenance Framework Agreement4.11.2026 15:00:00 CET | Press release
This framework agreement provides all entities subject to the French Public Procurement Code with simplified access to a support alternative enabling them to control their costs, preserve their freedom of technological choice and free themselves from vendor-imposed upgrade cycles Rimini Street, Inc. (Nasdaq: RMNI), the Software Support and Agentic AI ERP Company™ and the leading third-party support provider for Oracle, SAP and VMware software, today announced that it had been selected as the awardee of the third-party support service lots (TMA) by CANUT, the French public purchasing center specializing in digital technology and telecommunications. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261104431817/en/ Rimini Street Awarded CANUT Third-Party Maintenance Framework Agreement Eligible public organizations subject to the French Public Procurement Code can now benefit from Rimini Street services for their Oracle, SAP, VMw
Incyte to Present New Data Highlighting Progress Across its Hematology Portfolio at ASH 20264.11.2026 15:00:00 CET | Press release
New data in myeloproliferative neoplasms (MPNs) will include INCA033989, Incyte’s first-in-class, mutant calreticulin (mutCALR)-targeted monoclonal antibody, in first-line myelofibrosis (MF); and preclinical findings for Incyte’s next-generation mutCALR- and JAK2V617F-targeted compoundsUpdated results for INCA033989 in second-line MF and second-line essential thrombocythemia (ET) will build on previously presented datasetsLong-term Phase 1/2 data further characterize the potential of latarcibart (VGA039), an investigational Protein S-targeting antibody, as prophylaxis in adolescents and adults with von Willebrand disease (VWD)More than 30 abstracts will highlight progress across Incyte’s broader hematology portfolioIncyte will host an investor event and webcast on Saturday, December 12, 2026 from 7:30 – 9:00 p.m. CT (8:30 – 10:00 p.m. ET) Incyte (Nasdaq:INCY) today announced that new data highlighting progress across its hematology portfolio will be presented across more than 30 abstra
Zenitar Announces Initiation of International Randomized Study of Flonoltinib Maleate in Patients with Myelofibrosis and Related American Society of Hematology 2026 Meeting Presentations4.11.2026 15:00:00 CET | Press release
Chengdu Zenitar Biomedical Technology Co., Ltd. (Zenitar) is developing flonoltinib maleate (FM), a first-in-class oral JAK2/FLT3/CDK6 inhibitor for myeloproliferative neoplasms (MPNs), including myelofibrosis (MF) and polycythemia vera (PV). Zenitar launched randomized Phase 2 FM-MF-02 (NCT07750574) in the US, Canada and Brazil to select Phase 3 dose for JAKi-naïve and refractory MF. Randomized FMF-02 (NCT06457425) met its week-24 endpoints: superior SVR35 and TSS50 with FM 50/100mg versus ruxolitinib; previous data presented orally at ASH24 (#486) and ASH25 (#908). ASH 2026 presence covers FMF-02 long-term follow-up (oral presentation, #411, December 12, 4:30pm) and refractory PV Phase 2 data (poster, #3765, December 13, 6pm), both in Session 634. “Over the 15 years since the initial FDA approval of Ruxolitinib, JAKi have markedly improved the prognosis of many patients with MF. The long-term data show significant room for improvement for this key therapeutic class in terms of both e
Trained Therapeutix Discovery Appoints Andrew Glass as Chief Executive Officer4.11.2026 14:41:00 CET | Press release
Trained Therapeutix Discovery ("TTxD"), a pioneering immunotherapy company founded by the Jean Boulle Group and the Heritage Group, which is developing nanomedicines to regulate innate immunity, announces the appointment of Andrew Glass as Chief Executive Officer with immediate effect. Mr. Glass has more than 20 years of leadership experience in the life sciences industry as Chief Executive Officer of Vivasure Medical and previously from over 15 years in senior leadership roles at Abbott. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261104178009/en/ Andrew Glass, CEO, TTxD Following the previously announced changes to the Company’s Board earlier this year, Mr. Glass joins the Company as it transitions from preclinical stage to being a clinical-stage organisation. His expertise in developmental strategy, financing and organisational growth is focussed on expediting the delivery of the aims associated with TTxD’s proprietary
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom